{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:57:13Z","timestamp":1787320633736,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmogastro.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Gastrointestinal Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.esmogo.2025.100147","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:40:38Z","timestamp":1740382838000},"page":"100147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"PA","title":["Incidence and burden of anal cancer\u2014time to fight the growing disparities"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0293-9954","authenticated-orcid":false,"given":"E.S.L.","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6636-9818","authenticated-orcid":false,"given":"D.","family":"Verschoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-6144","authenticated-orcid":false,"given":"E.","family":"Segelov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.esmogo.2025.100147_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/17474124.2020.1775583","article-title":"A 2020 update of anal cancer: the increasing problem in women and expanding treatment landscape","volume":"14","author":"Lum","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100147_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(04)01410-X","article-title":"Cancer of the anal canal","volume":"5","author":"Clark","year":"2004","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100147_bib3","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/1055-9965.EPI-15-0044","article-title":"Anal cancer incidence in the United States, 1977-2011: distinct patterns by histology and behavior","volume":"24","author":"Shiels","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100147_bib4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","article-title":"Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Rao","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmogo.2025.100147_bib5","article-title":"Metastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm?","volume":"2012","author":"Dewdney","year":"2012","journal-title":"ISRN Oncol"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100147_bib6","first-page":"924","article-title":"International trends in anal cancer incidence rates","volume":"46","author":"Islami","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.esmogo.2025.100147_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102099","article-title":"Trends in incidence and survival from anal cancer and incidence of high-grade anal intraepithelial neoplasia in Denmark","volume":"77","author":"Urbute","year":"2022","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100147_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.soc.2016.07.009","article-title":"Uncommon anal neoplasms","volume":"26","author":"Roy","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.esmogo.2025.100147_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109542","article-title":"Treatment, outcome, and prognostic factors in non-metastatic anal cancer: the French nationwide cohort study FFCD-ANABASE","volume":"183","author":"Vendrely","year":"2023","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100147_bib10","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ijc.34811","article-title":"Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990-2021)","volume":"154","author":"Ho","year":"2024","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100147_bib11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1473-3099(19)30164-1","article-title":"Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis","volume":"19","author":"Lin","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100147_bib12","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100147_bib13","first-page":"401","article-title":"The increasing incidence of anal cancer: can it be explained by trends in risk groups?","volume":"71","author":"van der Zee","year":"2013","journal-title":"Neth J Med"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100147_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205105","article-title":"Anal cancer in high-income countries: increasing burden of disease","volume":"13","author":"Kang","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100147_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ijc.34269","article-title":"Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: a worldwide analysis","volume":"152","author":"Deshmukh","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.esmogo.2025.100147_bib16","series-title":"Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Anal Cancer","year":"2024"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100147_bib17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/djz219","article-title":"Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015","volume":"112","author":"Deshmukh","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100147_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CEJ.0000000000000842","article-title":"Global trends in anal cancer incidence and mortality","volume":"33","author":"Mignozzi","year":"2024","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100147_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale","volume":"148","author":"Clifford","year":"2021","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100147_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jnci\/djad214","article-title":"Human papillomavirus-associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates-United States, 2001-2019","volume":"116","author":"Gopalani","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100147_bib21","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1111\/ajt.15942","article-title":"Burden of anal squamous cell carcinoma, squamous intraepithelial lesions and HPV16 infection in solid organ transplant recipients: a systematic review and meta-analysis","volume":"20","author":"Albuquerque","year":"2020","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100147_bib22","doi-asserted-by":"crossref","first-page":"e1186","DOI":"10.1097\/DCR.0000000000002940","article-title":"Incidence of anal cancer and related risk factors in HIV-infected patients enrolled in the national prospective Spanish cohort CoRIS","volume":"66","author":"Sendagorta Cud\u00f3s","year":"2023","journal-title":"Dis Colon Rectum"},{"issue":"15-16","key":"10.1016\/j.esmogo.2025.100147_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00508-020-01622-z","article-title":"Trends in incidence of anal cancer in Austria, 1983-2016","volume":"132","author":"Heer","year":"2020","journal-title":"Wien Klin Wochenschr"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100147_bib24","doi-asserted-by":"crossref","first-page":"11462","DOI":"10.1002\/cam4.5865","article-title":"Temporal increase in the incidence of anal squamous cell carcinoma in Kentucky and factors associated with adverse outcomes","volume":"12","author":"O\u2019Brien","year":"2023","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100147_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/0284186X.2022.2048069","article-title":"Anal cancer in Sweden 2015-2019. Implementation of guidelines, structural changes, national registry and early results","volume":"61","author":"Johnsson","year":"2022","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100147_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25110","article-title":"Evidence of synergistic relationships between HIV and human papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status","volume":"21","author":"Looker","year":"2018","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100147_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QAD.0000000000002059","article-title":"Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection","volume":"33","author":"Aldersley","year":"2019","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100147_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/cid\/ciad205","article-title":"Human papillomavirus-associated anal cancer incidence and burden among US men, according to sexual orientation, human immunodeficiency virus status, and age","volume":"77","author":"Deshmukh","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100147_bib29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/QAD.0000000000002218","article-title":"Incidence and time trends of anal cancer among people living with HIV in Australia","volume":"33","author":"Jin","year":"2019","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100147_bib30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/jnci\/djad128","article-title":"Cumulative incidence of anal cancer since HIV or AIDS diagnosis in the United States","volume":"115","author":"Haas","year":"2023","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100147_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1158\/1055-9965.EPI-19-0601","article-title":"Risk of anal cancer following benign anal disease and anal cancer precursor lesions: a Danish nationwide cohort study","volume":"29","author":"Faber","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100147_bib32","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/DCR.0000000000001219","article-title":"What is the risk of anal carcinoma in patients with anal intraepithelial neoplasia III?","volume":"61","author":"Lee","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100147_bib33","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/ijc.34143","article-title":"A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer","volume":"151","author":"Faber","year":"2022","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100147_bib34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41416-018-0273-9","article-title":"Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis","volume":"120","author":"Gilbert","year":"2019","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100147_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jnci\/djad189","article-title":"Human papillomavirus vaccination and anal high-grade precancerous lesions and cancer-a real-world effectiveness study","volume":"116","author":"Baandrup","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"10.1016\/j.esmogo.2025.100147_bib36","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100147_bib37","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/ciy274","article-title":"A randomized, placebo-controlled trial of the quadrivalent human papillomavirus vaccine in human immunodeficiency virus-infected adults aged 27 years or older: AIDS Clinical Trials Group Protocol A5298","volume":"67","author":"Wilkin","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"10.1016\/j.esmogo.2025.100147_bib38","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1093\/cid\/ciac044","article-title":"Anal cancer screening and prevention: summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention sexually transmitted infection guidelines","volume":"74","author":"Barroso","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.esmogo.2025.100147_bib39","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/ijc.34199","article-title":"A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups","volume":"151","author":"Clarke","year":"2022","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100147_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cncy.22018","article-title":"Strategies for screening and early detection of anal cancers: a narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers","volume":"126","author":"Clarke","year":"2018","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100147_bib41","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/S2352-3018(22)00368-X","article-title":"Effect of the introduction of screening for cancer precursor lesions on anal cancer incidence over time in people living with HIV: a nationwide cohort study","volume":"10","author":"van der Zee","year":"2023","journal-title":"Lancet HIV"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100147_bib42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/cid\/ciz831","article-title":"Routine screening of anal cytology in persons with human immunodeficiency virus and the impact on invasive anal cancer: a prospective cohort study","volume":"71","author":"Revollo","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"24","key":"10.1016\/j.esmogo.2025.100147_bib43","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer","volume":"386","author":"Palefsky","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmogo.2025.100147_bib44","series-title":"New York State Department of Health AIDS Institute Clinical Guidelines. Screening for Anal Dysplasia and Cancer in Adults With HIV","author":"Hirsch","year":"2022"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100147_bib45","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/ijc.34850","article-title":"International Anal Neoplasia Society\u2019s consensus guidelines for anal cancer screening","volume":"154","author":"Stier","year":"2024","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100147_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270670","article-title":"Geographical risk pattern and temporal trends in incidence of HPV-related cancers in northern Thailand: a population-based study","volume":"17","author":"Sripan","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100147_bib47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s12885-019-5781-3","article-title":"Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review","volume":"19","author":"Lekoane","year":"2019","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100147_bib48","doi-asserted-by":"crossref","first-page":"e899","DOI":"10.1016\/S2214-109X(21)00143-1","article-title":"Global health in low-income and middle-income countries: a framework for action","volume":"9","author":"Olufadewa","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100147_bib49","doi-asserted-by":"crossref","first-page":"e1345","DOI":"10.1016\/S2214-109X(23)00305-4","article-title":"Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis","volume":"11","author":"Bruni","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100147_bib50","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.esmogo.2025.100147_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.esmogo.2025.100147_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100836","article-title":"Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis","volume":"34","author":"Dorji","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100147_bib53","first-page":"719","article-title":"Awareness of the causal association between human papillomavirus and anal cancer among US adults","volume":"35","author":"Atarere","year":"2024","journal-title":"Cancer Causes Control"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100147_bib54","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/bjc.2016.304","article-title":"Cancer incidence and mortality projections in the UK until 2035","volume":"115","author":"Smittenaar","year":"2016","journal-title":"Br J Cancer"}],"container-title":["ESMO Gastrointestinal Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:28:57Z","timestamp":1784557737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949819825000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"alternative-id":["S2949819825000160"],"URL":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100147","relation":{},"ISSN":["2949-8198"],"issn-type":[{"value":"2949-8198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and burden of anal cancer\u2014time to fight the growing disparities","name":"articletitle","label":"Article Title"},{"value":"ESMO Gastrointestinal Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100147"}}